Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, Ohio.
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Metabolic Translational Research Center, Endocrine and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio.
Surg Obes Relat Dis. 2014 Jan-Feb;10(1):29-35. doi: 10.1016/j.soard.2013.01.021. Epub 2013 Feb 11.
Potential mechanisms underlying the antidiabetic effects of Roux-en-Y gastric bypass (RYGB) include altered nutrient exposure in the gut. The aim of this study was to evaluate the effects of selective gut stimulation on glucose metabolism in an obese diabetic rat model.
Sixteen male Zucker diabetic fatty rats were randomly assigned to 1 of 2 groups: RYGB with gastrostomy tube (GT) insertion into the excluded stomach or a control group with GT insertion into the stomach. An insulin tolerance test (ITT), oral glucose tolerance test (OGTT), and mixed meal tolerance test (MMTT) were performed before and 14-28 days after surgery. A glucose tolerance test via GT (GTT-GT) and MMTT via GT were performed postoperatively.
Postoperatively, the RYGB group had significant decreases in weight and food intake. Both the ITT and OGTT tests revealed significantly improved glucose tolerance after RYGB. The GTT-GT showed a reversal of the improved glucose tolerance in the RYGB group. In response to meal stimulation, postoperatively, the RYGB group increased glucagon-like peptide 1 (GLP-1) secretion via the oral route and peptide YY secretion by both oral and GT routes.
When foregut exposure to nutrients was reversed after RYGB, the improvement in glucose metabolism was abrogated. This model can be extended to identify the role of gut in glucose homeostasis in type 2 diabetes.
Roux-en-Y 胃旁路术(RYGB)的抗糖尿病作用的潜在机制包括肠道中营养物质暴露的改变。本研究旨在评估选择性肠道刺激对肥胖糖尿病大鼠模型葡萄糖代谢的影响。
16 只雄性 Zucker 糖尿病肥胖大鼠随机分为 2 组:RYGB 组胃造口管(GT)插入到被排除的胃中,或对照组 GT 插入到胃中。手术前和手术后 14-28 天进行胰岛素耐量试验(ITT)、口服葡萄糖耐量试验(OGTT)和混合餐耐量试验(MMTT)。术后通过 GT 进行葡萄糖耐量试验(GTT-GT)和 MMTT。
术后 RYGB 组体重和摄食量明显下降。IT 和 OGTT 测试均显示 RYGB 后葡萄糖耐量明显改善。GTT-GT 显示 RYGB 组改善的葡萄糖耐量逆转。进食刺激后,RYGB 组通过口服途径增加胰高血糖素样肽 1(GLP-1)分泌,通过口服和 GT 途径增加肽 YY 分泌。
当 RYGB 后前肠暴露于营养物质时,葡萄糖代谢的改善被消除。该模型可以扩展到确定肠道在 2 型糖尿病中葡萄糖稳态中的作用。